| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Caliola Engineering is a woman-owned small business that provides systems, security, and software engineering services to the US Government. They specialize in wireless communications, cryptography, protected MILSATCOM, software defined radio, and unma...
Hilco/Wilson Smart Optical Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Plainville, MA. To find more information about Hilco/Wilson Smart Optical Solutions, please visit www.hilco-usa.com
Retirement Concepts is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Futures HealthCore is a Springfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.